首页
>>
产品中心
>>
蛋白产品
>>
重组蛋白
>
Recombinant Human FSTL1 Protein, C-10*His tag

Recombinant Human FSTL1 Protein, C-10*His tag

产品编号

KMH1119

别名

FSTL1蛋白, FRP, FSL1, OCC1, OCC 1, tsc36, MIR198, follistatin like 1

规格
  • 20ug
  • 50ug
  • 100ug
  • 200ug
  • 1mg
产品介绍
Catalog NumberKMH1119
AliasFSTL1蛋白, FRP, FSL1, OCC1, OCC 1, tsc36, MIR198, follistatin like 1
Size20ug, 50ug, 100ug, 200ug, 1mg
Product DescriptionKMH1119 Recombinant Human FSTL1 Protein, C-10*His tag contains the human FSTL1(21-308 aa) was expressed in Mammalian Cells.
Molecular NameFSTL1
Product Introduction (KMH1119) FSTL1通过调节细胞增殖、迁移和分化,参与免疫和生理过程。
Molecular Weight45-50 kDa
Expression SystemHEK293F Cells
SpeciesHuman
Concentration联系销售经理获得最新批次的浓度
Purity≥95%
SDS-PAGE
PurificationAffinity Purification
Uniprot IDQ12841
Storage ConditionStore the product under sterile conditions after opening at -80℃ for 12 months. Store the lyophilized powder at -20℃. Avoid repeated freeze-thaw cycles.
FormulationPBS
Shipping ConditionThis product is shipped on ice packs or dry ice.
BackgroundFollistatin-like 1, also known as FSTL1, is an activin-binding protein with similarity to follistatin. It contains an FS module, a follistatin-like sequence containing ten conserved cysteine residues, two EF-hand domains, a Kazal-like domain and a VWFC domain. This heparin binding protein is involved in the BMP signaling pathway, and may modulate the action of some growth factors on cell proliferation and differentiation. FSTL1 is thus suggested as a regulator of early mesoderm patterning, somitogenesis, myogenesis and neural development. FSTL1 is ubiquitously expressed in the majority of tissues in adult, with strongly expressed level in the mesenchymal component and excluded from the epithelium. In addition, this protein is thought to be an autoantigen associated with rheumatoid arthritis.
Endotoxin< 0.1 EU per ug
Protein FamilyOther protein
Biological ActivityMeasured by its binding ability in a functional ELISA. When Recombinant Human Follistatin‑like 1/FSTL1 is coated at 2 μg/mL (100 μL/well), the concentration of recombinant human BMP-4 that produces 50% of the optimal binding response is found to be approx
Product Declaration该产品仅供科研使用,不可直接用于人体或注射。
FAQ
  • 如何评估已表达蛋白的活性?

    可以通过特定的酶活性实验、受体结合实验或细胞实验来评估蛋白的生物活性。

  • 已表达蛋白的溶解性如何提高?

    可以通过优化表达条件、使用适当的去污剂或分子伴侣蛋白来提高蛋白的溶解性。

登录

还没有账号?立即注册

注册

已有账号?立即登录

立即询价